Crouse Health Online: Wellness is just a click away.
Share Share
  |  Connect with Us: 
large
med
small
Text Size
 

Health News



Gene Discovery May Move Personalized Stomach Cancer Treatment Forward

Gene Discovery May Move Personalized Stomach Cancer Treatment Forward

04/09/12

SUNDAY, April 8 (HealthDay News) -- An international team of researchers has identified hundreds of new genes that are mutated in stomach cancer, in a finding they say could lead to treatments tailored to the genetic make-up of individual stomach tumors.

Stomach cancer is the second leading cause of cancer death worldwide and kills more than 700,000 people a year, according to the World Health Organization. Treatment is often difficult and unsuccessful. In the United States, less than one-quarter of stomach cancer patients survive more than five years after diagnosis.

"Until now, the genetic abnormalities that cause stomach cancers are still largely unknown, which partially explain the overall poor treatment outcome," said the study's senior author, Dr. Patrick Tan, an associate professor in the Cancer and Stem Cell Biology Program at Duke-NUS Graduate Medical School, in a Duke University Medical Center news release.

Tan, who leads the Genomic Oncology Program at the Cancer Sciences Institute of Singapore, and colleagues from the National Cancer Center of Singapore used DNA sequencing technology to analyze tumor and normal tissue from stomach cancer patients. They identified more than 600 genes that were previously unknown to be mutated in stomach cancer.

Further analysis revealed that two genes -- FAT4 and ARID1A -- were mutated in 5 percent and 8 percent, respectively, of stomach cancers. In some patients, portions of the chromosome containing the two genes were missing. This provides further evidence that genetic defects affecting the two genes occur frequently in stomach cancer.

In lab experiments, the researchers found that changing the functioning of the two genes altered the growth of stomach cancer cells.

"More research is required to realize the clinical implications of these findings. ARID1A and FAT4 are likely also involved in many other cancer types, not just stomach cancer," Tan said.

The study appears online April 8 in Nature Genetics.

More information

The American Academy of Family Physicians has more about stomach cancer.

Copyright © 2012 HealthDay. All rights reserved.

Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.

OF INTEREST:
 

Latest News

Crouse Hospital Appoints Chief Information Officer
more >

MedEx Bedside Prescription Delivery Service

Free service offers convenience, patient education at discharge.
more >

Weight Loss Surgery

Is it right for you? Attend a free information seminar held twice monthly.
more >

Quality at Crouse

See how Crouse Hospital strives to provide the best in patient care.
more >

Cheer Up That Special Someone

Say get well or welcome a new arrival with a gift purchased right at Crouse.

more >

Make an Online Donation Now

Your donation of any amount helps support Crouse services & programs in a meaningful way.
more >

Shop Online Now

Say get well, thinking of you or welcome new baby with a unique gift from the Crouse Gift Shop.

more >